CXC-AG
CXC-AG is a division of CXC, solely focused on developing and commercializing research from top university laboratories. CXC-AG has strong links to McGill University, especially the Smith Lab which is renowned for developing lipochito-oligosaccharides (LCOs), which are arguably the biggest hit in biologicals, in use on hundreds of millions of acres worldwide.
Biologicals
BioFuelNet Canada Inks Research Deal with CXC-AG for 450 Bacterial Strains to Fight GHGs
The new strains have the potential to increase yields in the absence of abiotic stress.
Latest News
Herbicides
New Syngenta Herbicide Offers Sustainable Solution to Global Weed Resistance Crisis
The company's latest weed control solution, metproxybicyclone, has been...
Biologicals
Bayer and Kimitec Introduce Two New Biologicals Developed Through Their Partnership
Ambition Complete Gen2 and Ambition Secure Gen2 will be...
ABG Update Feature
Breaking Resistance: Syngenta’s Plinazolin Technology Offers New Hope for U.S. Growers
Learn how Syngenta’s breakthrough Plinazolin technology introduces a novel...
ABG Update Feature
R&D Leaders from Bayer, Corteva, Rovensa Next, and More Share Breakthroughs in Formulation Science
Panelists from a recent ABG LIVE webinar share insight...